Oral film and preparation method therefor, and oral smokeless product

By introducing cationic polymers into the oral membrane for electrostatic adsorption of nicotine, the problem of nicotine volatility is solved, achieving stable control of nicotine content and slow release, thus improving the user experience.

WO2026237068A1PCT designated stage Publication Date: 2026-11-19SHENZHEN HUABAO COLLABORATIVE INNOVATION TECH RES INST CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2025/095490
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-16
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

In the existing technology for preparing oral films containing free nicotine, the volatility of nicotine makes it difficult to control the content, and nicotine vapor accumulates in the production environment, affecting production safety and product consistency.

Method used

By introducing a positively charged cationic polymer to electrostatically adsorb negatively charged free nicotine, the binding force is enhanced, nicotine volatilization during preparation and storage is reduced, the release rate of nicotine in the oral film is regulated, and the nicotine content is kept stable.

Benefits of technology

It effectively reduces the volatilization of nicotine during preparation and storage, ensuring the stability of nicotine content in the product and slow release during use, thus improving the user experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2025095490_19112026_PF_FP_ABST
    Figure CN2025095490_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The present application discloses an oral film and a preparation method therefor, and an oral smokeless product. The oral film comprises an active agent and a film-forming material. The active agent comprises free nicotine and / or a nicotine salt. The oral film further comprises a cationic polymer. The oral film satisfies a relational expression shown in formula 1: (b / k) / a≥0.85, wherein: a is the parts by weight of the active agent; k is an empirical constant, and k=2.5; and b is the parts by weight of the cationic polymer. The oral film provided by the present application generates electrostatic adsorption between the negatively charged active agent and the positively charged cationic polymer, thereby inhibiting volatilization of the active agent during production and storage, facilitating control and stabilization of the active agent content in the oral film, and delaying release of the active agent.
Need to check novelty before this filing date? Find Prior Art

Description

A method for preparing an oral film and a mouth-held smokeless product Technical Field

[0001] This application belongs to the field of oral products technology, specifically relating to an oral film, its preparation method, and a smokeless oral product. Background Technology

[0002] Oral films are a new type of nicotine product that replaces mouth-held cigarettes and nicotine pouches. While ensuring the satisfaction of nicotine, oral films have the advantages of being thin, completely disintegrating, and not needing to be spat out. When using an oral film, it needs to be applied between the upper lip and upper gum. It is absorbed into the bloodstream through epithelial cells, reducing the irritation of nicotine (also known as nicotine alkaloids) on the stomach, which can cause vomiting and stomach cramps.

[0003] In existing technologies, the preparation of oral films containing free nicotine involves heating and drying to remove moisture. Free nicotine is a volatile active ingredient that easily volatilizes upon heating, leading to a decrease in nicotine content. Studies have shown that this process can cause more than 15% of nicotine to volatilize. This not only makes it difficult to control the nicotine content in the product, resulting in significant differences in nicotine content between different batches, but may also cause nicotine vapor to accumulate in the production environment, negatively impacting the environment.

[0004] Application content

[0005] In view of the problem that free nicotine in oral films containing free nicotine is prone to volatilization during production and storage in the prior art, this application provides an oral film, its preparation method and a mouth-held smokeless product.

[0006] The technical solution adopted in this application to solve the above-mentioned technical problems is as follows:

[0007] In a first aspect, embodiments of this application provide an oral membrane, the oral membrane comprising an active agent and a film-forming material, the active agent comprising free nicotine and / or nicotine salts, the oral membrane further comprising a cationic polymer, and the oral membrane satisfying the relationship shown in Formula 1.

[0008] (b / k) / a≥0.85 Equation 1

[0009] Where a is the weight of the surfactant; k is an empirical constant, k = 2.5; and b is the weight of the cationic polymer.

[0010] Optionally, the oral membrane satisfies the relationship shown in Equation 2, (b / k) / a < 1.2, b / k ≥ 2. Equation 2.

[0011] Optionally, the oral membrane satisfies the relationship shown in Equation 3, (b / k) / a < 1.05 Equation 3.

[0012] Optionally, the nicotine salt includes one or more of nicotine benzoate, nicotine levulinate, nicotine lactate, nicotine tartrate, nicotine citrate, and nicotine malate.

[0013] And / or, the cationic polymer includes one or more cationic modified products of chitosan, guar gum, cellulose, and starch; the cationic modification includes quaternization modification.

[0014] Optionally, the oral film comprises 1-20 parts of nicotine, 3-60 parts of cationic polymer, 1-40 parts of film-forming material, 0-15 parts of plasticizer and 0-1.5 parts of additives.

[0015] Optionally, the film-forming material includes one or more of polyvinyl alcohol, sodium alginate, xanthan gum, starch, hydroxypropyl methylcellulose, hydroxypropyl cellulose, pullulan, agar, and carrageenan.

[0016] Optionally, the plasticizer includes a polyol, which includes one or more of glycerol, propylene glycol, hexanediol, polyethylene glycol, dipropylene glycol, and 1,3-butanediol.

[0017] Optionally, the additives include at least one of pH adjusters, sweeteners, cooling agents, colorants, antioxidants, preservatives, saliva stimulants, and flavorings.

[0018] Optionally, the thickness of the oral membrane is 10-1000 μm.

[0019] Secondly, this application also provides a method for preparing an oral membrane, comprising the following steps:

[0020] The film-forming material and cationic polymer are added to water and stirred to dissolve, thus obtaining a mixed solution; nicotine is added to the mixed solution and mixed, followed by the addition of plasticizers and additives, and vacuum degassing is performed to obtain a coating solution;

[0021] The oral film is obtained by coating and drying the coating solution.

[0022] Thirdly, this application also provides a mouth-held smokeless product, the mouth-held smokeless product comprising at least one support layer and an oral membrane as described in any of the above claims or an oral membrane prepared by the above methods, wherein the support layer is disposed on at least one surface of the oral membrane.

[0023] The support layer and the oral membrane can be composited using an embossing and rolling cutting device.

[0024] In this application, a positively charged cationic polymer is introduced to facilitate electrostatic adsorption with negatively charged free nicotine, increasing the binding force between free nicotine and the cationic polymer. This reduces the amount of nicotine volatilized due to heat during the preparation of the oral film and prevents nicotine volatilization during storage, making the nicotine content in the oral film easier to control and maintain stability. Furthermore, by defining the relationship between nicotine and the cationic polymer as specified in Equation 1, the binding force between free nicotine and the cationic polymer is regulated, controlling the amount of nicotine volatilized from the oral film. This avoids the harm to the external environment and workers caused by excessive nicotine volatilization, and allows nicotine to be slowly released into the oral mucosa during use, thereby prolonging the feeling of satisfaction and providing a better user experience. Attached Figure Description

[0025] Figure 1 is an experimental data graph of mouse plasma nicotine concentration versus time curves for oral films of Examples 1, 3, 5 and Comparative Examples 1 and 2 of this application.

[0026] Figure 2 is a schematic diagram of a mouth-type smokeless product according to an embodiment of this application;

[0027] Figure 3 is a schematic diagram of a mouth-type smokeless product according to another embodiment of this application.

[0028] In the diagram: 1. Oral membrane; 2. Supporting layer. Detailed Implementation

[0029] To make the technical problems, technical solutions, and beneficial effects solved by this application clearer, the following detailed description is provided in conjunction with embodiments. It should be understood that the specific embodiments described herein are merely illustrative and are not intended to limit the scope of this application.

[0030] One embodiment of this application discloses an oral membrane, which includes an active agent and a film-forming material. The active agent includes free nicotine and / or nicotine salts. The oral membrane also includes a cationic polymer. The oral membrane satisfies the relationship shown in Formula 1.

[0031] (b / k) / a≥0.85 Equation 1

[0032] Where a is the weight of the surfactant; k is an empirical constant, k = 2.5; and b is the weight of the cationic polymer.

[0033] In this embodiment, by introducing a positively charged cationic polymer, the electrostatic adsorption between the polymer and negatively charged free nicotine is utilized to increase the binding force between free nicotine and the cationic polymer, thereby reducing the amount of nicotine volatilized due to heat during the preparation of the oral film. Simultaneously, this electrostatic adsorption also prevents nicotine volatilization during storage, making the nicotine content in the oral film easier to control and maintain stability. Furthermore, a lower amount of cationic polymer in the oral film leads to nicotine volatilization, while an increased amount makes nicotine release difficult, reducing the user experience. By limiting the relationship between nicotine and the cationic polymer to satisfy Equation 1, the binding force between free nicotine and the cationic polymer is regulated, controlling the amount of nicotine volatilization in the oral film, avoiding excessive nicotine volatilization and its harm to the external environment and staff. Simultaneously, it allows nicotine to be slowly released into the oral mucosa during use, thereby prolonging satisfaction and providing a better user experience. Specifically, the nitrogen atom in the nicotine molecule carries unbonded lone pairs of electrons, exhibiting a certain degree of negative charge. Therefore, compared to nonionic or negatively charged film-forming materials, nicotine exhibits a stronger electrostatic attraction with positively charged cationic polymers. In oral films, nicotine and cationic polymers adsorb each other through intermolecular forces such as electrostatic interactions, van der Waals forces, and hydrophobic interactions. Simultaneously, nicotine molecules desorb from the film-forming material due to molecular thermal motion and free diffusion. In other words, nicotine molecules in oral films are constantly in a dynamic equilibrium of adsorption and desorption with the cationic polymers.

[0034] During the use of oral patches, only nicotine molecules desorbed from the cationic polymer can penetrate into the oral mucosa and be absorbed. Therefore, the dynamic adsorption-desorption relationship between nicotine and the cationic polymer affects the rate at which nicotine detaches from the oral patch and penetrates into the oral mucosa. Specifically, the stronger the adsorption between nicotine and the cationic polymer, the slower the nicotine diffuses into the mucosa; conversely, the weaker the adsorption, the faster the nicotine diffuses. By adjusting the relationship between the amount of cationic polymer and nicotine added, the nicotine volatilization rate can be reduced, and the nicotine release rate can be effectively controlled, ensuring an appropriate duration of nicotine satisfaction and a better user experience.

[0035] There is no limit to the weight of nicotine; it can be added according to user needs. The weight of the cationic polymer only needs to satisfy the relationship shown in Equation 1 with the weight of nicotine.

[0036] In some embodiments, the oral membrane satisfies the relationship shown in Equation 2, where (b / k) / a < 1.2 and b / k ≥ 2 (Equation 2). By limiting the relationship between nicotine and the cationic polymer to satisfy Equation 2, the binding force between free nicotine and the cationic polymer is regulated, allowing nicotine to be slowly released into the oral mucosa, thereby prolonging the feeling of satisfaction and obtaining a better user experience.

[0037] In some embodiments, the oral membrane satisfies the relationship shown in Equation 3, (b / k) / a < 1.05 Equation 3. By limiting the relationship between nicotine and cationic polymer to satisfy Equation 3, the binding force between free nicotine and cationic polymer is controlled, ensuring a high total absorption of nicotine in the oral membrane and a short time to reach the nicotine absorption peak, thus providing the user with a strong sense of satisfaction.

[0038] It is understandable that when oral films simultaneously satisfy the relationships shown in Equations 2 and 3, i.e. 0.85≤(b / k) / a<1.05, b / k≥2, the amount of volatiles in the oral film is reduced during production and storage. At the same time, the release rate of nicotine during the use of the oral film can provide users with immediate satisfaction and a better user experience.

[0039] In some embodiments, the nicotine salt includes one or more of nicotine benzoate, nicotine acetylpropionate, nicotine lactate, nicotine tartrate, nicotine citrate, and nicotine malate.

[0040] In some embodiments, the cationic polymer includes one or more cationic modified products of chitosan, guar gum, cellulose, and starch. By selecting the above-mentioned cationic polymer, the adsorption force between free nicotine and the cationic polymer can be adjusted, allowing nicotine to be slowly released into the oral mucosa. The cationic modification includes quaternization modification.

[0041] In some embodiments, the oral membrane comprises 1-20 parts of nicotine, 3-60 parts of cationic polymer, 1-40 parts of film-forming material, 0-15 parts of plasticizer, and 0-1.5 parts of additives.

[0042] The weight parts of the film-forming material include, but are not limited to, 1 part, 5 parts, 10 parts, 15 parts, 20 parts, 25 parts, 30 parts, 35 parts or 45 parts.

[0043] The plasticizer is available in parts by weight, including but not limited to 0, 1, 3, 5, 7, 9, 11, 13, or 15 parts.

[0044] The mass content of the additives includes, but is not limited to, 0.1 parts, 0.2 parts, 0.3 parts, 0.5 parts, 0.7 parts, 0.9 parts, 1.1 parts, 1.3 parts, or 1.5 parts.

[0045] In some embodiments, the film-forming material includes one or more of polyvinyl alcohol, sodium alginate, xanthan gum, starch, hydroxypropyl methylcellulose, hydroxypropyl cellulose, pullulan, agar, and carrageenan. By selecting the above-mentioned film-forming material, the strength of the oral membrane can be adjusted to facilitate its adhesion to the oral cavity.

[0046] In some embodiments, the plasticizer comprises a polyol, including one or more of glycerol, propylene glycol, hexanediol, polyethylene glycol, dipropylene glycol, and 1,3-butanediol. By adding the plasticizer, the toughness of the oral membrane is adjusted to facilitate its use.

[0047] In some embodiments, the adjuvants include at least one selected from pH adjusters, sweeteners, cooling agents, colorants, antioxidants, preservatives, salivary stimulants, and flavorings. The addition of these adjuvants enhances the mouthfeel of the oral film. Specifically, the pH adjuster is selected from sodium carbonate, sodium bicarbonate, or tartaric acid. The antioxidant may be ascorbic acid, the preservative may be sodium benzoate, and the sweetener may be sucralose.

[0048] In some embodiments, the thickness of the oral membrane is 10-1000 μm. By limiting the thickness of the oral membrane, the comfort of using the oral membrane is improved.

[0049] An embodiment of this application also provides a method for preparing an oral membrane, comprising the following steps:

[0050] The film-forming material and cationic polymer are added to water and stirred to dissolve, thus obtaining a mixed solution; nicotine is added to the mixed solution and mixed, followed by the addition of plasticizers and additives, and vacuum degassing is performed to obtain a coating solution;

[0051] The oral film is obtained by coating and drying the coating solution.

[0052] Specifically, the viscosity of the coating solution is 4000-20000 cp.

[0053] As shown in Figures 2 and 3, an embodiment of this application also discloses a mouth-type smokeless product, which includes at least one support layer 2 and the oral membrane 1 described above, or an oral membrane 1 prepared by the above method, wherein the support layer 2 is disposed on at least one surface of the oral membrane 1.

[0054] As shown in Figure 2, in one embodiment, the mouth-type smokeless product has a support layer 2 disposed on one surface of the oral membrane 1.

[0055] As shown in Figure 3, in another embodiment, the mouth-type smokeless product may also have two support layers 2 respectively disposed on the two surfaces of the oral membrane 1.

[0056] Specifically, the support layer 2 is a soluble or insoluble nonwoven fiber, including but not limited to spun or nonwoven alginate fibers, gluten fibers, microperforated plates derived from alginate, carrageenan, and other polymer adhesives, and combinations thereof. By providing the support layer, the oral membrane 1 is prevented from contacting the outside environment, thus preventing moisture absorption and adhesion of the smokeless oral product. The user can move or remove the product at any time during use.

[0057] The present application will be further illustrated by the following examples.

[0058] Example 1

[0059] This embodiment is used to illustrate the oral membrane and its preparation method disclosed in this application.

[0060] Weigh out 4g of nicotine, 14g of cationic cellulose, 30g of hydroxypropyl methylcellulose, 0.5g of sucralose, 0.5g of cooling agent, 1g of flavoring, and 5g of glycerin.

[0061] The above components are dissolved and mixed evenly with water to obtain a film-forming slurry. The film-forming solution is coated onto a template and dried in an oven at 65°C for 2 hours. The slurry is then cut into small pieces of a certain size to obtain nicotine sustained-release oral films.

[0062] Example 2-11

[0063] Examples 2-11 illustrate the oral film disclosed in this application, and differ from Example 1 in that they use the formulation in Table 1.

[0064] Comparative Examples 1-4

[0065] Comparative Examples 1-4 are used to illustrate the oral films disclosed in this application. The difference between them and Example 1 is that they use the formulations in Table 1.

[0066] Table 1

[0067] The cationic polymers in the above examples come from the following sources:

[0068] Performance testing

[0069] Nicotine volatilization rate test of oral films: During the preparation of oral films, moisture needs to be removed by heating and baking. During this process, nicotine will also volatilize. In order to investigate the nicotine volatilization of oral film samples during the preparation process, the nicotine content of each oral film sample was tested using gas chromatography-mass spectrometry.

[0070] The nicotine content in the oral film and the loss rate relative to the initial addition amount were calculated according to the formulations given in the examples and comparative examples. The actual nicotine content in the oral film after heating and drying was measured. The volatility rate was calculated as [(theoretical nicotine content - actual nicotine content in the oral film) / theoretical nicotine content)] * 100%.

[0071] Tests on the effective duration and absorption volume of oral patch absorption: Isoflurane was injected into a respiratory anesthesia machine. After the rats were anesthetized, 50 μL of distilled water was dripped into the rat's mouth. Then, a 2 mg / patch of oral patch was applied to the buccal cavity. Blood samples were collected from the jugular vein at 0, 15 min, 30 min, 60 min, 90 min, 120 min, 150 min, 180 min, 210 min, 240 min, 360 min, 480 min, and 6000 min after administration into heparin sodium tubes. After centrifugation, the supernatant plasma was collected and analyzed by UPLC-MS / MS. Key pharmacokinetic parameters were analyzed using DAS2.0 pharmacokinetic software, which calculated the effective duration, total absorption AUC(0-t), and time to peak concentration. A threshold limit of 5 ng / mL*min was used; the effective duration was defined as the time during which the nicotine plasma concentration exceeded this threshold.

[0072] Table 2

[0073] The test results from Example 1 and Comparative Examples 1 and 2 show that the nicotine volatilization rate of the oral film without the addition of cationic polymer is as high as 76%. This is because the nicotine in the examples exhibits a stronger adsorption effect with the cationic polymer, making it less prone to volatilization during heating. Therefore, the nicotine content in the final product is closer to the initial addition amount. This difference further proves that the cationic polymer proposed in this application can inhibit the volatilization of free nicotine. When a cationic polymer is added to the oral film, its nicotine volatilization rate is significantly reduced. Furthermore, when the added mass of nicotine and cationic polymer satisfies (b / k) / a ≥ 0.85, the nicotine volatilization rate is less than 15%.

[0074] As shown in the test results of Examples 1 and 2-11 and Figure 1, when the added mass of nicotine and cationic polymer satisfies 0.85≤(b / k) / a<1.2 and b / k≥2, the effective absorption time of nicotine is between 60-150 minutes, which allows nicotine to be slowly released into the oral mucosa, thereby prolonging the feeling of satisfaction and obtaining a better user experience.

[0075] When the added mass of nicotine and cationic polymer satisfies 0.85≤(b / k) / a<1.05 and b / k≥2, the total absorbable amount of nicotine in the oral film is ≥15ng / mL*h, the time to reach the peak nicotine absorption is short, and the user obtains a strong sense of satisfaction.

[0076] The test results of Examples 1, 3, 6, and 9-11 show that when other cationic polymers are used, the oral films also have a low volatility, and the nicotine in them can be slowly released into the oral mucosa, which can prolong the user's satisfaction.

[0077] The above description is merely a preferred embodiment of this application and is not intended to limit this application. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of this application should be included within the protection scope of this application.

Claims

1. An oral film comprising an active agent and a film forming material, the active agent comprising free nicotine and / or a nicotine salt, characterised in that, The oral film further comprises a cationic polymer, the oral film satisfies the following relation, (b / k) / a≥0.85 Formula 1 Wherein, a is the weight part of the active agent; k is an empirical constant, k=2.5; b is the weight part of the cationic polymer.

2. The oral film according to claim 1, wherein, The oral film satisfies the following relation, (b / k) / a<1.2, b / k≥2 Formula 2.

3. The oral film according to claim 1 or 2, characterized in that, The oral film satisfies the following relation, (b / k) / a<1.05 Formula 3.

4. The oral film according to claim 1, wherein, The nicotine salt comprises one or more of nicotine benzoate, nicotine levulinic acid salt, nicotine lactate, nicotine tartrate, nicotine citrate, nicotine malate; And / or, the cationic polymer comprises one or more of cationic modified products of chitosan, guar gum, cellulose, starch; the cationic modification comprises quaternary ammonium modification.

5. The oral film according to claim 1, wherein The oral film comprises 1-20 parts of the active agent, 3-60 parts of the cationic polymer, 1-40 parts of the film-forming material, 0-15 parts of the plasticizer and 0-1.5 parts of the auxiliary agent.

6. The oral film according to claim 5, wherein, The film-forming material comprises one or more of polyvinyl alcohol, sodium alginate, xanthan gum, starch, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, pullulan, agar, carrageenan.

7. The oral film according to claim 5, wherein The plasticizer comprises polyhydric alcohol, the polyhydric alcohol comprises one or more of glycerol, propylene glycol, hexylene glycol, polyethylene glycol, dipropylene glycol, 1,3-butanediol.

8. The oral film according to claim 5, wherein, The auxiliary agent comprises at least one of pH adjuster, sweetener, cooling agent, colorant, antioxidant, preservative, saliva stimulant and essence.

9. A process for preparing the oral film according to any one of claims 1 to 8, characterized in that, Comprising the following steps: The film-forming material and the cationic polymer are added into water to be stirred and dissolved to obtain a mixed solution; the active agent is added into the mixed solution to be mixed, then the plasticizer and the auxiliary agent are added, vacuum defoaming treatment is performed to obtain a coating solution; The coating solution is coated and dried to obtain the oral film.

10. A smokeless oral product, characterized in that, The oral film comprises at least one supporting layer and the oral film as claimed in any one of claims 1-8, or the oral film prepared by the method of claim 9, the supporting layer is arranged on at least one surface of the oral film.